Mitochondrial Fission and Fusion in Alzheimer Disease

阿尔茨海默病中的线粒体裂变和融合

基本信息

  • 批准号:
    7800269
  • 负责人:
  • 金额:
    $ 31.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-03-01 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Early changes in AD brain include loss of synapses. AB, considered to have a central role in the pathogenesis of AD, bind to dendritic spines and cause synaptic dysfunction. However, the mechanisms responsible for AB-induced synaptic dysfunction and spine loss are not firmly established. Notably, synaptic terminals have abundant mitochondria which play an indispensable role at these sites. Along this line, mitochondrial dysfunction is an early prominent feature of AD neurons. Mitochondria are dynamic organelles that undergo continual fission and fusion events which are regulated by a machinery involving large dynamin-related GTPase that exert opposing effects, e.g., dynamin-like protein 1 (DLP1) and Fis1 for fission, and mitofusins (Mfn1 and Mfn2C) and OPA1 for fusion. These mitochondria fission and fusion proteins control not only mitochondrial number and morphology but also mitochondrial distribution and function. Indeed, defects in the mitochondrial fission/fusion balance and thus, the morphology and distribution have the potential to cause localized energy and calcium imbalance, which is especially damaging to polarized cells such as neurons, resulting in cellular dysfunction and death. Our preliminary studies suggest that the normally strict regulation of mitochondria morphology and distribution is impaired in AD neurons and fibroblasts which may be caused by differential expression of mitochondrial fission/fusion proteins induced by AB. Our central hypothesis is that AB induces mitochondrial dysfunction and synaptic abnormalities via its toxic effect on mitochondrial fission/fusion. Four aims will be pursued: Aim1) ADDLs induce mitochondrial dysfunction and synaptic abnormalities via its toxic effect on mitochondrial fission/fusion in vitro; Aim2) To Explore the Mechanisms of ADDL-induced DLP1 Reduction; Aim3) mutant PS1 causes mitochondrial abnormalities and neuronal dysfunction at least in part through its interaction with DLP1 and impaired balance in mitochondrial fission/fusion; Aim 4) DLP1 reduction underlies mitochondrial abnormalities and synaptic loss in vivo. PUBLIC HEALTH RELEVANCE: AB-caused synaptic dysfunction and spine loss is an early change and the most robust correlate of AD- associated cognitive deficits, however the underlying mechanism is not firmly established. It is known that mitochondria play an indispensable role in synaptic terminals and the balance of mitochondrial fission/fusion is critical for mitochondrial distribution and function. Our preliminary studies suggest the potential involvement of an impaired balance of mitochondrial fission/fusion in the pathogenesis of AD, in this application, we propose to investigate whether AB cause synaptic dysfunction and mitochondrial abnormalities via its toxic effect on the balance of mitochondrial fission and fusion.
描述(申请人提供):AD大脑的早期变化包括突触丢失。AB被认为在AD的发病机制中起核心作用,它与树突棘结合并导致突触功能障碍。然而,AB诱导的突触功能障碍和脊椎丢失的机制尚未确定。值得注意的是,突触终末有丰富的线粒体,在这些部位发挥着不可或缺的作用。沿着这条线,线粒体功能障碍是AD神经元的早期显著特征。线粒体是经历连续分裂和融合事件的动态细胞器,参与调节的机制包括发挥相反作用的大型动力蛋白相关GTP酶,例如用于分裂的动力素样蛋白1(DLP1)和FIS1,以及用于融合的有丝分裂蛋白(Mfn1和Mfn2C)和OPA1。这些线粒体分裂和融合蛋白不仅控制线粒体的数量和形态,而且还控制线粒体的分布和功能。事实上,线粒体分裂/融合平衡的缺陷以及线粒体的形态和分布可能会导致局部的能量和钙失衡,这对神经元等极化细胞尤其有害,导致细胞功能障碍和死亡。我们的初步研究表明,AD神经元和成纤维细胞对线粒体形态和分布的严格调控受到损害,这可能是由于AB诱导的线粒体分裂/融合蛋白的差异表达所致。我们的中心假设是AB通过对线粒体分裂/融合的毒性作用而导致线粒体功能障碍和突触异常。Aim1)ADDLS通过对线粒体分裂/融合的毒性作用在体外诱导线粒体功能障碍和突触异常;AIM2)探讨ADDR诱导DLP1减少的机制;Aim3)突变型PS1至少部分通过与DLP1相互作用和破坏线粒体分裂/融合平衡而导致线粒体异常和神经元功能障碍;目的4)DLP1减少是体内线粒体异常和突触丧失的基础。公共卫生相关性:AB引起的突触功能障碍和脊柱丢失是AD相关认知缺陷的早期变化和最强有力的相关性,然而潜在的机制尚未确定。众所周知,线粒体在突触末端起着不可或缺的作用,线粒体分裂/融合的平衡对线粒体的分布和功能至关重要。我们的初步研究表明,线粒体分裂/融合平衡受损可能参与了AD的发病机制,在这一应用中,我们建议探讨AB是否通过对线粒体分裂/融合平衡的毒性作用而导致突触功能障碍和线粒体异常。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xiongwei Zhu其他文献

Xiongwei Zhu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xiongwei Zhu', 18)}}的其他基金

Role of Mettl3-dependent RNA m6A dysregulation in Alzheimer's disease
Mettl3 依赖性 RNA m6A 失调在阿尔茨海默病中的作用
  • 批准号:
    10739065
  • 财政年份:
    2023
  • 资助金额:
    $ 31.86万
  • 项目类别:
Research Education Component
研究教育部分
  • 批准号:
    10474608
  • 财政年份:
    2021
  • 资助金额:
    $ 31.86万
  • 项目类别:
Research Education Component
研究教育部分
  • 批准号:
    10675675
  • 财政年份:
    2021
  • 资助金额:
    $ 31.86万
  • 项目类别:
Research Education Component
研究教育部分
  • 批准号:
    10263716
  • 财政年份:
    2021
  • 资助金额:
    $ 31.86万
  • 项目类别:
Epigenomic Mechanism of Parkinson's Disease
帕金森病的表观基因组机制
  • 批准号:
    8738730
  • 财政年份:
    2013
  • 资助金额:
    $ 31.86万
  • 项目类别:
Epigenomic Mechanism of Parkinson's Disease
帕金森病的表观基因组机制
  • 批准号:
    8547489
  • 财政年份:
    2013
  • 资助金额:
    $ 31.86万
  • 项目类别:
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise
阿尔茨海默病中的线粒体动力学异常和线粒体功能障碍
  • 批准号:
    9261605
  • 财政年份:
    2013
  • 资助金额:
    $ 31.86万
  • 项目类别:
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise
阿尔茨海默病中的线粒体动力学异常和线粒体功能障碍
  • 批准号:
    8829930
  • 财政年份:
    2013
  • 资助金额:
    $ 31.86万
  • 项目类别:
Training in Neurodegenerative Diseases
神经退行性疾病培训
  • 批准号:
    10614554
  • 财政年份:
    2013
  • 资助金额:
    $ 31.86万
  • 项目类别:
Training in Neurodegenerative Diseases
神经退行性疾病培训
  • 批准号:
    8869054
  • 财政年份:
    2013
  • 资助金额:
    $ 31.86万
  • 项目类别:

相似海外基金

cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
  • 批准号:
    10436626
  • 财政年份:
    2021
  • 资助金额:
    $ 31.86万
  • 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10557162
  • 财政年份:
    2021
  • 资助金额:
    $ 31.86万
  • 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
  • 批准号:
    21K08199
  • 财政年份:
    2021
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10330464
  • 财政年份:
    2021
  • 资助金额:
    $ 31.86万
  • 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
  • 批准号:
    9807741
  • 财政年份:
    2019
  • 资助金额:
    $ 31.86万
  • 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2018
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
  • 批准号:
    18K15937
  • 财政年份:
    2018
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
  • 批准号:
    1813152
  • 财政年份:
    2016
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
  • 批准号:
    16K09118
  • 财政年份:
    2016
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了